Skip to main content
. 2016 Jul-Aug;24(4):191–195. doi: 10.1590/1413-785220162404158362

Table 1. Descriptive statistics for study sample.

Total (N=34) p
Age 67.1 Â ± 9.8 (42 - 88) 0.466
Female 18 (52.9%) 0.809
Arthroplasty 0.488
- Partial 8 (23.5%)
- Total 26 (76.5%)
Right Side 15 (53.6%) 0.030
Cementation 0.304
- Hybrid 9 (26.5%)
- Non-cemented 25 (73.5%)
Fracture 15 (44.1%) 0.063
Tumor Type 0.903
- Bladder 1 (2.9%)
- Breast 9 (26.5%)
- Gastrointestinal 7 (20.6%)
- Glioblastoma 1 (2.9%)
- Lung 1 (2.9%)
- Lymphoma 1 (2.9%)
- Melanoma 1 (2.9%)
- Multiple Myeloma 5 (14.7%)
- Prostate 8 (23.5%)
Length Of Stay 14.3 Â ± 24.2 (42 - 114) 0.954
Death 15 (44.1%) 0.809
Time Until Death 425.8 Â ± 388.5 (6 - 1419) 0.019
Radiotherapy 1.000
- No 30 (88.2%)
- Post 2 (5.9%)
- Pre 2 (5.9%)
Walking Time 12.6 ± 19.1 (0 - 82) 0.030
Infection 1 (2.9%) 0.560
Surgical Debridement 1 (2.9%) 0.560
Antibiotic Treatment (Ciprofloxacin/Pseudomonas) 1 (2.9%) 0.560